HOME
PRODUCT
SOLUTION
SUPPORT
ABOUT
CONTACT
2023.09
ISO9001
2022.12
CELNOVTE primary antibody - Material safety data sheet (MSDS)
2021.06
Celnovte biotechnology got CE certificate.
Celnovte PR NordiQC Assessment
Celnovte self-cloned primary antibodies won optimal in NordiQC assessment for 6 consecutive years.
2024.01
Founded in 2010, Celnovte is headquartered in Zhengzhou, China for reagent and instrument development and manufacturing. It also has subsidiaries in Shenzhen for instrument R&D, in Suzhou for research-use product development, and in Maryland(USA) for reagent R&D. Our extensive medical instrument manufacturing facilities span 1000m² in Shenzhen, China, and 3000m² in Zhengzhou, China. We also have a GMP-certified lab at the class 10,000 and 100,000 levels, along with supporting research, production, and quality inspection equipment.
Celnovte HER2 NordiQC Assessment
2023.03
ISO13485
Celnovte Biotechnology CE Approval